BlackKLHawkinsRA: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg, 71: 342–346, 1989.
2.
BruhnHFrahmJGyngelML: Noninvasive differentiation of tumors with use of localized H-1 MR Spettroscopy in vivo initial experience in patients with cerebral tumors. Radiology, 172: 541, 1989.
3.
IwamaTYamadaH: Correlation between magnetic resonance imaging and histopathology of intracranial glioma. Neurol Res, 13: 48–54, 1991.
4.
KleihuesPBurgerPCScheithauerBW: Histological Typing of Tumors of the Central Nervous System. WHO International Histological Classification of Tumors series. 2nd edn. Springer-Verlag, Berlin Heidelberg1993.
5.
MazziottaJC: The continuing challenge of primary brain tumor management: The contribution of positron emission tomography. Ann Neurol, 29: 345–346, 1991.
6.
RosaMLCappelliniC: Elementi generali di diagnostica neuroradiologica nei tumori cerebrali. Rivista di Neuroradiologia, 5: 7–14, 1992.
7.
TervonenOForbesG: Diffuse «fibrillary» astrocytomas: Correlation of MRI features with histopathologic parameters and tumor grade. Neuroradiology, 34: 173–178, 1992.
8.
ToviMLiliaA: Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol, 31: 417–429, 1990.
9.
WatanabeMTanakaRTakedaN: Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology, 34: 463–469, 1992.
10.
YoshiiYKomatsuY: Malignancy and Viability of Intraparenchymal Brain Tumors: Correlation Between Gd-DTPA Contrast MR Images and Proliferative Potentials. Acta Neurochir (Wien), 117: 187–194, 1992.